| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b44b545635c0ac8550ce45ad3923f1fe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate |
2001-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a707d38b64695e62a394a895c0ddecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88a660098d8ac82eeb6c56e1bc7a5a72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bd124821ac3b03ca28b3483c42530db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f04425bac7e756c6c2046f0e05683e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f9fcc32cd15c8bf22f542c97bfc8bdd |
| publicationDate |
2003-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-0301161-A2 |
| titleOfInvention |
New polymorphic forms of 5- [4- [2- [N-methyl-N- (2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate and a process for their preparation |
| abstract |
The present invention relates to a novel polymorph and pseudopolymorph of 5- [4- [2-N-methyl-N- (2-pyridyl) -amino] -ethoxy] -benzyl] -thiazolidine-2,4-dione maleate of formula (I) forms. The invention also relates to a pharmaceutical composition comprising the novel polymorphic form or a mixture thereof and a pharmaceutically acceptable carrier. Polymorphic forms of the present invention are more effective as antidiabetic agents than the prior art 5- [4- [2-N-methyl-N- (2-pyridyl) amino] ethoxy] benzyl] thiazolidine-2,4-dione maleate . SHE |
| priorityDate |
2000-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |